X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (11) 11
animals (8) 8
oncology (7) 7
cell line, tumor (6) 6
lung cancer (5) 5
mutation (5) 5
resistance (5) 5
apoptosis (4) 4
cancer (4) 4
cell biology (4) 4
expression (4) 4
kinases (4) 4
lung neoplasms - pathology (4) 4
rats (4) 4
respiratory system (4) 4
cancer research (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
cell proliferation (3) 3
gefitinib (3) 3
heart (3) 3
male (3) 3
mechanisms (3) 3
medicine (3) 3
neoplasms (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
regenerative medicine (3) 3
stem cells (3) 3
therapy (3) 3
acquired-resistance (2) 2
activation (2) 2
adult (2) 2
biophysics (2) 2
blockade (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
cardiac & cardiovascular systems (2) 2
cardiac progenitor cells (2) 2
cardiac progenitors (2) 2
cardiotoxicity (2) 2
cell culture (2) 2
cell proliferation - drug effects (2) 2
cell survival (2) 2
cell survival - drug effects (2) 2
cells, cultured (2) 2
chemotherapy (2) 2
cytotoxicity (2) 2
drug synergism (2) 2
egfr (2) 2
epidermal growth factor (2) 2
epithelial-mesenchymal transition (2) 2
erlotinib (2) 2
female (2) 2
growth-factor receptor (2) 2
immunotherapy (2) 2
in-vivo (2) 2
lung neoplasms (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - genetics (2) 2
lung neoplasms - metabolism (2) 2
lung-cancer cells (2) 2
materials science (2) 2
materials science, biomaterials (2) 2
mice (2) 2
mice, inbred balb c (2) 2
mice, nude (2) 2
middle aged (2) 2
myocardial-infarction (2) 2
myocardium - cytology (2) 2
myocytes, cardiac - cytology (2) 2
myocytes, cardiac - drug effects (2) 2
myocytes, cardiac - physiology (2) 2
nsclc (2) 2
pathway (2) 2
pd-l1 (2) 2
pemetrexed (2) 2
pharmacology & pharmacy (2) 2
phenotypes (2) 2
porosity (2) 2
progression (2) 2
pulmonary and respiratory medicine (2) 2
quinazolines - administration & dosage (2) 2
randomized phase-1 trial (2) 2
rats, wistar (2) 2
receptor, epidermal growth factor - antagonists & inhibitors (2) 2
receptor, epidermal growth factor - genetics (2) 2
research (2) 2
research article (2) 2
research paper (2) 2
respiratory tract diseases (2) 2
rodents (2) 2
signal transduction - drug effects (2) 2
statistical analysis (2) 2
stem cells - drug effects (2) 2
stem cells - physiology (2) 2
stem-cells (2) 2
surgery (2) 2
survival (2) 2
tissue engineering (2) 2
tumor-infiltrating lymphocytes (2) 2
tyrosine kinase inhibitors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal of experimental & clinical cancer research : CR, ISSN 1756-9966, 05/2019, Volume 38, Issue 1, pp. 222 - 12
The third generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) osimertinib has been initially approved for T790M positive... 
Chemotherapy | Epidermal growth factor | Lung cancer | Cloning | Mutation | Kinases | Tumors | Apoptosis | Resistance | Osimertinib | Epidermal Growth Factor Receptor | Non-Small Cell Lung Cancer | Pemetrexed | Cisplatin
Journal Article
Molecular Cancer, ISSN 1476-4598, 12/2012, Volume 11, Issue 1, pp. 91 - 91
Background: The epidermal growth factor receptor (EGFR) is an established target for anti-cancer treatment in different tumour types. Two different strategies... 
Erlotinib | Cetuximab | ADCC | Lung cancer | EGFR | KINASE INHIBITOR GEFITINIB | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR-CELLS | LUNG-CANCER CELLS | CHEMOTHERAPY | PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | ONCOLOGY | COMBINATION TREATMENT | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Carcinoma, Non-Small-Cell Lung - chemistry | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Lung Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Receptor, Epidermal Growth Factor - metabolism | Antibodies, Monoclonal, Humanized - administration & dosage | Female | Quinazolines - administration & dosage | Cell Membrane - metabolism | Receptor, ErbB-2 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Binding Sites - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Cell Survival - drug effects | Lung Neoplasms - chemistry | Receptor, Epidermal Growth Factor - chemistry | Carcinoma, Non-Small-Cell Lung - immunology | Drug Synergism | Xenograft Model Antitumor Assays | Lung Neoplasms - immunology | Animals | Analysis of Variance | Mice, Nude | Protein Stability - drug effects | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Mice, Inbred BALB C | Carcinoma, Non-Small-Cell Lung - drug therapy | Antibody-Dependent Cell Cytotoxicity - drug effects | Trastuzumab | Proteins | Enzymes | Statistical analysis | Epidermal growth factor | Rodents | Cytotoxicity | Ligands | Mutation | Kinases | Experiments | Cancer therapies
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, p. S1150
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2016, Volume 11, Issue 7, pp. 1051 - 1063
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4302 - 4302
Abstract Myelodysplastic Syndrome (MDS) is a multifaceted disease of Hematopoietic Stem Cells characterized by myeloproliferation associated with mono- or... 
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 10/2013, Volume 33, Issue 7, pp. 3677 - 3687
Journal Article
Pharmacological Research, ISSN 1043-6618, 01/2018, Volume 127, pp. 15 - 25
Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis... 
Cardiotoxicity | Cardiac progenitor cells | Imatinib mesylate | Kit | MYOCARDIAL-INFARCTION | RANDOMIZED PHASE-1 TRIAL | KINASE INHIBITORS | CANCER | CHRONIC MYELOID-LEUKEMIA | ADULT-MOUSE | HEART | INDUCED CARDIOTOXICITY | THERAPY | STEM-CELL | PHARMACOLOGY & PHARMACY | Index Medicus
Journal Article